Literature DB >> 1741813

Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation.

M T Pato, D L Murphy, C L DeVane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741813     DOI: 10.1097/00004714-199106000-00024

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  13 in total

1.  Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity.

Authors:  P Pacher; Z Ungvari; V Kecskemeti; A Koller
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  The Relevance of Glutathione Reductase Inhibition by Fluoxetine to Human Health and Disease: Insights Derived from a Combined Kinetic and Docking Study.

Authors:  Ozlem Dalmizrak; Kerem Teralı; Evelyn Bright Asuquo; Izzet Hamdi Ogus; Nazmi Ozer
Journal:  Protein J       Date:  2019-10       Impact factor: 2.371

3.  Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.

Authors:  Dorothy Sit; James M Perel; James F Luther; Stephen R Wisniewski; Joseph C Helsel; Katherine L Wisner
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

Review 4.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

5.  Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes.

Authors:  János Magyar; Norbert Szentandrássy; Tamás Bányász; Valéria Kecskeméti; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-26       Impact factor: 3.000

Review 6.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 7.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

8.  Fluoxetine Decreases the Proliferation and Adipogenic Differentiation of Human Adipose-Derived Stem Cells.

Authors:  Bo Kyung Sun; Ji Hye Kim; Joon-Seok Choi; Sung-Joo Hwang; Jong-Hyuk Sung
Journal:  Int J Mol Sci       Date:  2015-07-22       Impact factor: 5.923

9.  Corticosterone facilitates fluoxetine-induced neuronal plasticity in the hippocampus.

Authors:  Katsunori Kobayashi; Yumiko Ikeda; Minoru Asada; Hirofumi Inagaki; Tomoyuki Kawada; Hidenori Suzuki
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

10.  Fluoxetine induced suicidal erythrocyte death.

Authors:  Kashif Jilani; Sigrid Enkel; Rosi Bissinger; Ahmad Almilaji; Majed Abed; Florian Lang
Journal:  Toxins (Basel)       Date:  2013-07-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.